Chemical transfection reagents induce intracellular Ca2+ signals in TRPA1-expressing cells
Alina MiliciiD, Andrei SegaliD, Justyna B. StartekiD, Karel TalaveraiD
Abstract
Transient receptor potential ankyrin 1 (TRPA1) is a polymodal sensory ion channel whose activity is influenced not only by chemical ligands but also by the physical properties of the plasma membrane. This raises the possibility that membrane-active compounds used routinely in cell biology may alter TRPA1 function. We investigated the acute effects of two widely used chemical transfection reagents, Lipofectamine 3000 and Mirus TransIT-293, on intracellular Ca2+; signaling and TRPA1 activity. For this, we monitored intracellular Ca2+; dynamics using ratiometric Fura-2 imaging in CHO cells stably expressing mouse TRPA1 (CHO-mTRPA1), parental CHO-WT cells, and primary mouse dorsal root ganglion (DRG) neurons. Transfection reagent preparations were applied at different concentrations under controlled temperature and low-flow conditions. The contribution of TRPA1 and Ca2+; influx was assessed using the selective TRPA1 inhibitor HC-030031 and the broad-spectrum Ca2+; channel blocker ruthenium red. We found that Lipofectamine 3000 induced concentration-dependent, irregular Ca2+; transients in CHO-mTRPA1 cells, while simultaneously inhibiting the constitutive TRPA1-dependent Ca2+; activity observed under basal conditions. Its inhibitory effect was evident at concentrations below those producing substantial cellular activation and was rapidly reversible after washout. At higher concentrations, Lipofectamine-induced Ca2+; responses were only partially suppressed by TRPA1 inhibition, indicating the involvement of additional mechanisms. Consistent with this, Lipofectamine also induced Ca2+; transients in CHO-WT cells and primary DRG neurons, where both extracellular Ca2+; influx and intracellular Ca2+; mobilization contributed to the responses. Analysis of the components of the Lipofectamine 3000 formulation further revealed distinct effects of Lipofectamine and the P3000 enhancer. Mirus TransIT-293 similarly induced Ca2+; transients in CHO-mTRPA1 cells and DRG neurons. In CHO-mTRPA1 cells, its response was concentration-dependent and strongly reduced by HC-030031, whereas the response in DRG neurons showed little sensitivity to TRPA1 inhibition. We conclude that chemical transfection reagents can acutely alter intracellular Ca2+; homeostasis and modulate TRPA1 activity. Their effects involve both TRPA1-dependent and TRPA1-independent mechanisms and differ substantially between formulations and cell types. These findings identify membrane-active transfection reagents as previously underappreciated modulators of sensory ion-channel function and highlight their potential to influence the interpretation of experiments performed in transfected cells.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 0
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- TRPA1 channel activation by synthetic lipid nanoparticles
Alina Milici, Justyna B. Startek, … Karel Talavera·bioRxiv·May 5, 2026
- Transient Receptor Potential Ankyrin1 channel is endogenously expressed in T cells and regulates immune functions
S. S. Sahoo, R. K. Majhi, … S. Chattopadhyay·bioRxiv·Apr 29, 2019
- Mechanisms governing irritant-evoked activation and calcium modulation of TRPA1
J. Zhao, J. V. Lin King, … D. Julius·bioRxiv·Dec 26, 2019
- Human TRPA1 is an inherently mechanosensitive bilayer-gated ion channel
P. M. Zygmunt, L. Moparthi·bioRxiv·Mar 5, 2020
- A novel TRPA1 gain-of-function variant associated with painful sensory neuropathy acts through a PIP2 gating mechanism
Maddalena Comini, Tanadet Pipatpolkai, … David Bennett·bioRxiv·Aug 17, 2026
- Structural basis of TRPV1 modulation by endogenous bioactive lipids
W. R. Arnold, A. S. Mancino, … Y. Cheng·bioRxiv·May 11, 2023